SUSQUEHANNA INTERNATIONAL GROUP, LLP - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 19 filers reported holding IBERE PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$158,513
-9.4%
15,899
-10.2%
0.00%
Q3 2022$175,000
-55.2%
17,699
-55.6%
0.00%
Q2 2022$391,000
+35.8%
39,906
+35.9%
0.00%
Q1 2022$288,000
-51.0%
29,367
-50.0%
0.00%
Q4 2021$588,000
+100.0%
58,734
+100.0%
0.00%
Q3 2021$294,000
-0.3%
29,3670.0%0.00%
Q2 2021$295,000
+1.7%
29,3670.0%0.00%
Q1 2021$290,00029,3670.00%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q2 2022
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,875,700,0003.00%
Wealthspring Capital LLC 231,182$2,317,0000.50%
KRYGER CAPITAL Ltd 385,240$3,860,0000.22%
Schechter Investment Advisors, LLC 210,692$2,111,0000.19%
Sage Mountain Advisors LLC 89,180$894,0000.11%
Context Capital Management, LLC 115,053$1,153,0000.09%
Magnetar Financial LLC 784,909$7,865,0000.08%
ARISTEIA CAPITAL, L.L.C. 350,000$3,507,0000.06%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 36,569$366,0000.05%
Bulldog Investors, LLP 15,000$150,0000.04%
View complete list of IBERE PHARMACEUTICALS shareholders